Adjusted Trial Balance

$\backslash$table$[[,$Debit,Credit$],[$Cash$,2100,],[$Accounts Receivable,$41,800,],[$Notes Receivable,$10,000,],[$Interest Receivable,$600,],[$Inventory$,32,700,],[$Prepaid Insurance,$1,200,],[$Land$,20,000,],[$Buildings$,150,000,],[$Equipment$,71,800,],[$Patent$,8,000,],[$Allowance for Doubtful Accounts,,$4000],[$Accumulated Depreciation$-$Buildings,,$54,000],[$Accumulated Depreciation$-$Equipment,,$32,350],[$Accounts Payable,,$27,300],[$Salaries and Wages Payable,,$2,200],[$Notes Payable $($due April $30,2028),,11,000],[$Income Taxes Payable,,$15,000],[$Interest Payable,,$4,600],[$Notes Payable $($due in $2033),,35,000],[$Common Stock,,$50,000],[$Retained Earnings,,$63,600],[$Dividends$,12,000,],[$Sales Revenue,,$905,000],[$Interest Revenue,,$600],[$Gain on Disposal of Plant Assets,,$1,125],[$Bad Debt Expense,$3500,],[$Cost of Goods Sold,$633,500,],[$Depreciation Expense,$14975,],[$Income Tax Expense,$15000,],[$Insurance Expense,$2400,],[$Interest Expense,$4600,],[$Other Operating Expenses,$1000,],[$Amortization Expense,$$1,205,775,$$$1,205,775$